Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia.
Sweet K, Komrokji R, Padron E, Cubitt CL, Turner JG, Zhou J, List AF, Sallman DA, Dawson JL, Sullivan DM, Chavez J, Shah BD, Lancet JE. Sweet K, et al. Among authors: dawson jl. Clin Cancer Res. 2020 Jan 1;26(1):54-60. doi: 10.1158/1078-0432.CCR-19-2169. Epub 2019 Oct 21. Clin Cancer Res. 2020. PMID: 31636097 Free PMC article. Clinical Trial.
Real-world incidence of patient-reported dyspnoea with ticagrelor.
Prosser AE, Dawson JL, Koo K, O'Kane KM, Ward MB, Woodman RJ, Mangoni AA, Phillips CJ. Prosser AE, et al. Among authors: dawson jl. Ther Adv Drug Saf. 2018 Aug 9;9(10):577-584. doi: 10.1177/2042098618788991. eCollection 2018 Oct. Ther Adv Drug Saf. 2018. PMID: 30283625 Free PMC article.
XPO1 inhibitor combination therapy with bortezomib or carfilzomib induces nuclear localization of IκBα and overcomes acquired proteasome inhibitor resistance in human multiple myeloma.
Turner JG, Kashyap T, Dawson JL, Gomez J, Bauer AA, Grant S, Dai Y, Shain KH, Meads M, Landesman Y, Sullivan DM. Turner JG, et al. Among authors: dawson jl. Oncotarget. 2016 Nov 29;7(48):78896-78909. doi: 10.18632/oncotarget.12969. Oncotarget. 2016. PMID: 27806331 Free PMC article.
85 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page